Corteva, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
CTVA$12.17+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (Unaudited)
| (In millions) | Three Months Ended March 31, | |
|---|---|---|
| 2026 | 2025 | |
| Operating activities | ||
| Net income (loss) | $723 | $656 |
| (Income) loss from discontinued operations after income taxes | 2 | 11 |
| Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities: | ||
| Depreciation and amortization | 297 | 296 |
| Provision for (benefit from) deferred income tax | (52) | (122) |
| Net periodic pension and OPEB (benefit) cost, net | (3) | 10 |
| Pension and OPEB contributions | (48) | (51) |
| Net (gain) loss on sales of property, businesses, consolidated companies and investments | 3 | (4) |
| Restructuring and asset related charges - net | 92 | 22 |
| Other net loss | 157 | 75 |
| Changes in assets and liabilities, net | ||
| Accounts and notes receivable | (2,810) | (2,505) |
| Inventories | 439 | 379 |
| Accounts payable | (221) | (190) |
| Deferred revenue | (790) | (667) |
| Other assets and liabilities | (674) | (11) |
| Cash provided by (used for) operating activities - continuing operations | (2,885) | (2,101) |
| Cash provided by (used for) operating activities - discontinued operations | (6) | (8) |
| Cash provided by (used for) operating activities | (2,891) | (2,109) |
| Investing activities | ||
| Capital expenditures | (81) | (94) |
| Proceeds from sales of property, businesses and consolidated companies - net of cash divested | — | 8 |
| Investments in and loans to nonconsolidated affiliates | (3) | — |
| Proceeds from sales and maturities of investments | 8 | 62 |
| Other investing activities, net | (1) | (10) |
| Cash provided by (used for) investing activities | (77) | (34) |
| Financing activities | ||
| Net change in borrowings (less than 90 days) | 521 | 745 |
| Proceeds from debt | 268 | 637 |
| Payments on debt | (22) | (14) |
| Repurchase of common stock | (250) | (270) |
| Proceeds from exercise of stock options | 17 | 35 |
| Dividends paid to stockholders | (121) | (116) |
| Other financing activities, net | (24) | (22) |
| Cash provided by (used for) financing activities | 389 | 995 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | (5) | 21 |
| Increase (decrease) in cash, cash equivalents and restricted cash equivalents | (2,584) | (1,127) |
| Cash, cash equivalents and restricted cash equivalents at beginning of period | 4,725 | 3,422 |
| Cash, cash equivalents and restricted cash equivalents at end of period 1 | $2,141 | $2,295 |
- See Note 5 - Supplementary Information, to the interim Consolidated Financial Statements, for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.